Item 2.05. Costs Associated with Exit or Disposal Activities.

On December 27, 2012, Invacare Corporation (the "Company") issued a press release, attached as Exhibit 99.2 and incorporated herein by reference, announcing that due to a decline in production, the Company has initiated an immediate workforce reduction at its Taylor Street manufacturing facility in Elyria, Ohio. The expected decline in production results principally from the Company's previously announced consent decree of injunction with the United States Food and Drug Administration (the "FDA"), which was approved late last week by the United States District Court for the Northern District of Ohio.

The reduction will result in 143 associates being laid off. For those associates who have been laid off, Invacare will offer 60 days continuance of pay and benefits which is expected to result in restructuring charges in the fourth quarter of 2012 to be paid in the first quarter of 2013 in an amount not to exceed $1.25 million on a pre-tax basis. These charges are the only material charges the Company expects to incur in connection with the announced workforce reduction.

Item 8.01. Other Events.
On December 21, 2012, the Company announced that the United States District Court for the Northern District of Ohio (the "Court") approved the terms of the previously announced consent decree of injunction with the FDA. A copy of the Company's December 21, 2012 press release announcing the approval by the Court of the consent decree is attached as Exhibit 99.1 and incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.
(d) Exhibits. Exhibit Number Description
99.1 Press Release, dated December 21, 2012.
99.2 Press Release, dated December 27, 2012.

---